The role of microglia in multiple sclerosis

Multiple sclerosis (MS) is an autoimmune disease of the central nervous system (CNS). Microglia are the resident innate immune cells in the CNS; they play an important role in the processes of demyelination and remyelination in MS. Microglia can function as antigen-presenting cells and phagocytes. In the past, microglia were considered to be the same cell type as macrophages, and researchers have different opinions about the role of microglia in MS. This review focuses on the original classification of microglia and their role in the pathogenesis of MS. Moreover, we present a hypothetical model for the role of microglia in the pathogenesis of MS based on recent findings.

[1]  H. Neumann,et al.  Debris clearance by microglia: an essential link between degeneration and regeneration , 2008, Brain : a journal of neurology.

[2]  Kenneth J. Smith,et al.  Demyelination: The Role of Reactive Oxygen and Nitrogen Species , 1999, Brain pathology.

[3]  Hsiao-Fang Liang,et al.  Noninvasive detection of cuprizone induced axonal damage and demyelination in the mouse corpus callosum , 2006, Magnetic resonance in medicine.

[4]  Hans Lassmann,et al.  The Immunopathology of Multiple Sclerosis: An Overview , 2007, Brain pathology.

[5]  A. Bar-Or,et al.  Comparison of polarization properties of human adult microglia and blood‐derived macrophages , 2012, Glia.

[6]  P. Gebicke-haerter,et al.  Expression and regulation of cyclooxygenase-2 in rat microglia. , 1997, European journal of biochemistry.

[7]  I. Holtman,et al.  Demyelination during multiple sclerosis is associated with combined activation of microglia/macrophages by IFN-γ and alpha B-crystallin , 2014, Acta Neuropathologica.

[8]  B. Scheithauer,et al.  Inflammatory cortical demyelination in early multiple sclerosis. , 2011, The New England journal of medicine.

[9]  Ukpong B. Eyo,et al.  Microglial Hv1 proton channel promotes cuprizone‐induced demyelination through oxidative damage , 2015, Journal of neurochemistry.

[10]  J. Prineas,et al.  Multiple sclerosis: Capping of surface immunoglobulin G on macrophages engaged in myelin breakdown , 1981, Annals of neurology.

[11]  Tracy J. Yuen,et al.  M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination , 2013, Nature Neuroscience.

[12]  F Barkhof,et al.  Post-mortem MRI-guided sampling of multiple sclerosis brain lesions: increased yield of active demyelinating and (p)reactive lesions. , 2001, Brain : a journal of neurology.

[13]  R. Franklin,et al.  Macrophage depletion impairs oligodendrocyte remyelination following lysolecithin‐induced demyelination , 2001, Glia.

[14]  I. Amit,et al.  Host microbiota constantly control maturation and function of microglia in the CNS , 2015, Nature Neuroscience.

[15]  F. Jadidi-Niaragh,et al.  Th17 Cell, the New Player of Neuroinflammatory Process in Multiple Sclerosis , 2011, Scandinavian journal of immunology.

[16]  K. Schuurman,et al.  Microglia in normal appearing white matter of multiple sclerosis are alerted but immunosuppressed , 2013, Glia.

[17]  Chao Zhao,et al.  Macrophage-depletion induced impairment of experimental CNS remyelination is associated with a reduced oligodendrocyte progenitor cell response and altered growth factor expression , 2005, Neurobiology of Disease.

[18]  B. Castellano,et al.  Activated microglial cells acquire an immature dendritic cell phenotype and may terminate the immune response in an acute model of EAE , 2010, Journal of Neuroimmunology.

[19]  H. Lassmann,et al.  Oxidative damage in multiple sclerosis lesions , 2011, Brain : a journal of neurology.

[20]  W. Streit.  Microglia as neuroprotective, immunocompetent cells of the CNS , 2002, Glia.

[21]  K. Schuurman,et al.  Phenotyping primary human microglia: Tight regulation of LPS responsiveness , 2012, Glia.

[22]  M. Rodriguez,et al.  Indictment of the microglia as the villain in multiple sclerosis , 1997, Neurology.

[23]  M. Barnett,et al.  The macrophage in MS: just a scavenger after all? Pathology and pathogenesis of the acute MS lesion , 2006, Multiple sclerosis.

[24]  H. Lassmann,et al.  Explorer NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury , 2012 .

[25]  A. Uccelli,et al.  Can we switch microglia's phenotype to foster neuroprotection? Focus on multiple sclerosis , 2014, Immunology.

[26]  F. Ginhoux,et al.  Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages , 2010, Science.

[27]  H. D. de Vries,et al.  Severe oxidative damage in multiple sclerosis lesions coincides with enhanced antioxidant enzyme expression. , 2008, Free radical biology & medicine.

[28]  Simon Hametner,et al.  Disease-specific molecular events in cortical multiple sclerosis lesions , 2013, Brain : a journal of neurology.

[29]  K. Blomgren,et al.  Free radicals, mitochondria, and hypoxia-ischemia in the developing brain. , 2006, Free radical biology & medicine.

[30]  L. Bö,et al.  NAD(P)H:quinone oxidoreductase 1 expression in multiple sclerosis lesions. , 2006, Free radical biology & medicine.

[31]  V. Perry,et al.  Microglial physiology: unique stimuli, specialized responses. , 2009, Annual review of immunology.

[32]  J. Gensel,et al.  IL-4 Signaling Drives a Unique Arginase+/IL-1β+ Microglia Phenotype and Recruits Macrophages to the Inflammatory CNS: Consequences of Age-Related Deficits in IL-4Rα after Traumatic Spinal Cord Injury , 2014, The Journal of Neuroscience.

[33]  E. Benveniste.  Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis , 1997, Journal of Molecular Medicine.

[34]  F. Rosenbauer,et al.  Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways , 2013, Nature Neuroscience.

[35]  P. Villoslada,et al.  A Trifluoromethyl Analogue of Celecoxib Exerts Beneficial Effects in Neuroinflammation , 2013, PloS one.

[36]  J. Parratt,et al.  Multiple sclerosis: Distribution of inflammatory cells in newly forming lesions , 2009, Annals of neurology.

[37]  Peter K. Stys,et al.  Inefficient clearance of myelin debris by microglia impairs remyelinating processes , 2015, The Journal of experimental medicine.

[38]  C. Brosnan,et al.  Expression of inducible nitric oxide synthase and nitrotyrosine in multiple sclerosis lesions. , 2001, The American journal of pathology.

[39]  M. Graeber,et al.  Functional plasticity of microglia: A review , 1988, Glia.

[40]  W. Brück,et al.  Molecular Changes in White Matter Adjacent to an Active Demyelinating Lesion in Early Multiple Sclerosis , 2009, Brain pathology.

[41]  H. Weiner,et al.  Role of the innate immune system in the pathogenesis of multiple sclerosis , 2010, Journal of Neuroimmunology.

[42]  O. Bizzozero,et al.  Elevated protein carbonylation in the brain white matter and gray matter of patients with multiple sclerosis , 2005, Journal of neuroscience research.

[43]  W. Hickey.  The pathology of multiple sclerosis: a historical perspective 1 Supported in part by award NS 27321. 1 , 1999, Journal of Neuroimmunology.

[44]  H. D. de Vries,et al.  Nrf2 and DJ1 are consistently upregulated in inflammatory multiple sclerosis lesions. , 2010, Free radical biology & medicine.

[45]  E. Benveniste.  Cytokines: influence on glial cell gene expression and function. , 1992, Chemical immunology.

[46]  V. Perry,et al.  Review: Activation patterns of microglia and their identification in the human brain , 2013, Neuropathology and applied neurobiology.

[47]  S. Goerdt,et al.  Macrophage activation and polarization: nomenclature and experimental guidelines. , 2014, Immunity.

[48]  L. Lue,et al.  Immune phenotypes of microglia in human neurodegenerative disease: challenges to detecting microglial polarization in human brains , 2015, Alzheimer's Research & Therapy.

[49]  M. Olah,et al.  Identification of a microglia phenotype supportive of remyelination , 2012, Glia.

[50]  S. Amor,et al.  Activation Status of Human Microglia Is Dependent on Lesion Formation Stage and Remyelination in Multiple Sclerosis , 2015, Journal of neuropathology and experimental neurology.

[51]  C. Trebst,et al.  Characterisation of microglia during de- and remyelination: Can they create a repair promoting environment? , 2012, Neurobiology of Disease.

[52]  H. Weiner.  A shift from adaptive to innate immunity: a potential mechanism of disease progression in multiple sclerosis , 2008, Journal of Neurology.

[53]  S. Love,et al.  Elevated myeloperoxidase activity in white matter in multiple sclerosis , 2008, Neuroscience Letters.

[54]  E. Ponomarev,et al.  Microglial cell activation and proliferation precedes the onset of CNS autoimmunity , 2005, Journal of neuroscience research.

[55]  G. Wolswijk.  Oligodendrocyte survival, loss and birth in lesions of chronic-stage multiple sclerosis. , 2000, Brain : a journal of neurology.

[56]  Robert C. Wolpert,et al.  A Review of the , 1985 .

[57]  K. Pahan,et al.  Myelin Basic Protein-primed T Cells Induce Neurotrophins in Glial Cells via α5β3 Integrin* , 2007, Journal of Biological Chemistry.

[58]  Marco Prinz,et al.  Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease , 2014, Nature Reviews Neuroscience.

[59]  H. Weiner,et al.  Differential roles of microglia and monocytes in the inflamed central nervous system , 2014, The Journal of experimental medicine.

[60]  I. Majsterek,et al.  Advances in antioxidative therapy of multiple sclerosis. , 2013, Current medicinal chemistry.

[61]  R. Poston,et al.  Pathology, histochemistry and immunocytochemistry of lesions in acute multiple sclerosis , 1989, Journal of the Neurological Sciences.

[62]  E. Frohman,et al.  Multiple sclerosis--the plaque and its pathogenesis. , 2006, The New England journal of medicine.

[63]  Rajagopal N. Aravalli,et al.  Toll-like Receptors in Defense and Damage of the Central Nervous System , 2007, Journal of Neuroimmune Pharmacology.

[64]  M. Stangel,et al.  Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned , 2014, Front. Cell. Neurosci..

[65]  B. Becher,et al.  Experimental autoimmune encephalomyelitis repressed by microglial paralysis , 2005, Nature Medicine.

[66]  J. Pollard,et al.  A Lineage of Myeloid Cells Independent of Myb and Hematopoietic Stem Cells , 2012, Science.

[67]  C. Meisel,et al.  Microglial Activation Milieu Controls Regulatory T Cell Responses , 2013, The Journal of Immunology.

[68]  F. Gay,et al.  Early cellular events in multiple sclerosis Intimations of an extrinsic myelinolytic antigen , 2006, Clinical Neurology and Neurosurgery.

[69]  Christine Stadelmann,et al.  Extensive Cortical Remyelination in Patients with Chronic Multiple Sclerosis , 2007, Brain pathology.

[70]  W. Tompkins,et al.  Spontaneous T cell apoptosis in feline immunodeficiency virus (FIV)-infected cats is inhibited by IL2 and anti-B7.1 antibodies. , 2004, Veterinary immunology and immunopathology.

[71]  H. Mehmet,et al.  Maturation-dependent sensitivity of oligodendrocyte lineage cells to apoptosis: implications for normal development and disease , 2008, Cell Death and Differentiation.

[72]  M. Barnett,et al.  Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion , 2004, Annals of neurology.

[73]  C. Wegner,et al.  Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. , 2008, Brain : a journal of neurology.

[74]  Tom C. Freeman,et al.  Transcriptome-Based Network Analysis Reveals a Spectrum Model of Human Macrophage Activation , 2014, Immunity.